Forecast Period
|
2024-2028
|
Market Size (2022)
|
USD 2.10 billion
|
CAGR (2023-2028)
|
9.01%
|
Fastest Growing Segment
|
Lung Cancer
|
Largest Market
|
North America
|
Market Overview
Global Oncology Nutrition Market has valued at USD 2.10 billion in 2022
and is anticipated to project impressive growth in the forecast period with a
CAGR of 9.01% through 2028. The global oncology nutrition market refers to the
healthcare segment focused on providing specialized nutritional products and
services to cancer patients. Cancer and its treatment can significantly impact
a patient's nutritional needs and overall health. Oncology nutrition aims to
address these challenges by providing tailored solutions to support patients
during their cancer journey.
Key Market Drivers
Rising Cancer Incidence
The global oncology nutrition market is witnessing a significant surge
in demand, and one of the key drivers behind this growth is the alarming
increase in cancer incidence worldwide. As cancer continues to affect more
lives each year, the need for specialized nutritional support has never been
greater. Cancer has reached epidemic proportions, with its incidence steadily
rising across the globe. According to the World Cancer Research Fund, new
cancer cases are projected to increase by approximately 60% by 2040. This surge
in cancer diagnoses is creating a substantial pool of potential patients who
require oncology nutrition products and services. Cancer is not a singular
disease but rather a group of diseases with various types and stages. Each type
of cancer and individual patient may have unique nutritional needs. This
diversity within the cancer patient population has driven the development of a
wide range of oncology nutrition solutions tailored to specific requirements. Cancer
and its treatments, including chemotherapy, radiation therapy, and surgery, can
lead to a host of nutritional challenges. These challenges include weight loss,
muscle wasting, malnutrition, loss of appetite, and difficulty swallowing.
Oncology nutrition plays a crucial role in addressing these issues, enhancing
patients' quality of life and overall health. Adequate nutrition is vital for
patients undergoing cancer treatment. Nutritional support can help patients
better tolerate treatments, maintain their strength, and recover more swiftly
from the side effects of therapy. This, in turn, can improve treatment efficacy
and reduce complications, ultimately benefiting both patients and healthcare
systems. The rising cancer incidence has also led to increased emphasis on
cancer prevention and survivorship. Nutrition plays a pivotal role in both
aspects of cancer care. Nutritional interventions are being used to reduce the
risk of cancer development and improve the long-term health of cancer
survivors, further expanding the market for oncology nutrition products and
services. With the increasing recognition that each cancer patient's
nutritional needs are unique, there has been a growing trend toward
personalized nutrition plans. Healthcare providers are tailoring dietary
recommendations to individual patients, taking into account their specific
cancer type, treatment regimen, and overall health status. Cancer knows no
boundaries, affecting people worldwide. As the importance of proper nutrition
in cancer care becomes more widely acknowledged, the global oncology nutrition
market is expanding its reach. It is not confined to developed countries but
also serves patients in developing nations, creating a more extensive market
footprint.
Nutritional Challenges in Cancer Patients
The global oncology nutrition market has been experiencing significant
growth, and one of the pivotal factors propelling this expansion is the
recognition of nutritional challenges faced by cancer patients. The journey of
a cancer patient is fraught with various difficulties, and maintaining proper
nutrition is a critical aspect of their care. Cancer and its treatments often
lead to weight loss and malnutrition in patients. The metabolic changes caused
by the disease can result in muscle waste and a decrease in body weight.
Malnutrition can compromise the patient's overall health and weaken their
ability to tolerate treatment. Many cancer patients experience a loss of
appetite, a condition known as anorexia-cachexia syndrome. This loss of
interest in food can result from both the cancer itself and the side effects of
treatment. Oncology nutrition products and interventions are designed to
address this challenge by providing nutrient-dense solutions that are easier for
patients to consume. Certain cancers, particularly those affecting the throat
or esophagus, can cause difficulty in swallowing, known as dysphagia. This
condition makes it challenging for patients to eat regular meals. Oncology
nutrition includes solutions like liquid diets and tube feeding, which
circumvent the need for traditional solid food intake. Proper nutrition plays a
pivotal role in improving the quality of life for cancer patients. Malnutrition
and associated symptoms can lead to fatigue, weakness, and a diminished sense
of well-being. Oncological nutrition products are formulated to combat these
issues, helping patients feel better during their treatment journey. Nutritional
support is vital to help patients better tolerate the rigors of cancer treatment,
including chemotherapy, radiation therapy, and surgery. Adequate nutrition can
enhance treatment efficacy by ensuring that the patient's body is strong enough
to withstand the demands of therapy. This, in turn, can lead to better
treatment outcomes. The recognition that cancer patients have unique
nutritional needs has driven the development of personalized nutrition plans.
Healthcare providers tailor dietary recommendations to each patient, taking
into account factors such as cancer type, treatment regimen, and overall health
status. This individualized approach is a significant driver of growth in the
oncology nutrition market. The field of oncology nutrition is characterized by
continuous innovation. Companies are investing in research and development to
create new and improved nutritional products and services that cater to the
evolving needs of cancer patients. These innovations include specialized oral
supplements, enteral and parenteral nutrition solutions, and dietary guidelines
specifically for cancer patients.
Advancements in Medical Research
The global oncology nutrition market is experiencing remarkable growth,
with advancements in medical research playing a pivotal role in its expansion.
As our understanding of cancer and its treatment continues to evolve, so too
does our recognition of the critical role that nutrition plays in the
well-being and recovery of cancer patients. Medical research has deepened our
understanding of the complexities of cancer. We now know that cancer is not a
single disease but a group of diseases with distinct characteristics. This
nuanced understanding has led to the development of tailored nutritional
interventions designed to address the unique needs of different cancer types
and stages. Research has shed light on the profound impact of nutrition on
cancer patients' outcomes. It has become increasingly clear that maintaining
proper nutrition is essential for both managing the side effects of cancer
treatment and improving patients' overall quality of life. Advancements in
medical research have revealed how nutrition can mitigate the adverse side
effects of cancer treatments such as chemotherapy and radiation therapy. Proper
nutrition can help patients better tolerate treatment, reducing the severity of
symptoms such as nausea, vomiting, and fatigue. Research has shown that
nutrition plays a pivotal role in supporting the immune system, which is
crucial in the fight against cancer. Nutritional interventions can boost immune
function, potentially enhancing the body's ability to combat cancer cells and
reduce the risk of complications during treatment. Medical research has
emphasized the importance of personalized medicine, and this approach has
extended to oncology nutrition. Research findings have led to the development
of individualized nutrition plans that consider factors such as the patient's
specific cancer type, treatment regimen, and overall health status. These
personalized plans are more effective in addressing the unique nutritional
challenges of each patient. Advancements in research have driven innovation in
the development of oncology nutrition products. Companies in the market are
investing in research and development to create improved oral nutritional
supplements, enteral and parenteral nutrition solutions, and dietary guidelines
tailored to cancer patients' needs.
Market Innovation
The global oncology nutrition market is experiencing robust growth, and
one of the key engines propelling this expansion is market innovation. In the
quest to provide effective solutions for cancer patients' unique nutritional
needs, companies are pushing the boundaries of research and development,
creating novel products and services. Market innovation has led to a diverse
portfolio of oncology nutrition products and services. Companies are
continually developing new and improved solutions that cater to the evolving
needs of cancer patients. This includes a wide range of oral nutritional
supplements, enteral and parenteral nutrition options, and dietary guidelines
tailored specifically for cancer patients. Innovations in formulation
techniques have resulted in more effective oncology nutrition products. These
products are designed to provide essential nutrients in an easily digestible
form. Enhanced formulations ensure that patients receive the necessary nutrients,
even if they have difficulty eating solid foods due to cancer and its
treatments. Market innovation has driven the adoption of personalized nutrition
plans in oncology. Healthcare providers are recognizing that each cancer
patient's nutritional needs are unique, and customized dietary recommendations
are becoming the norm. These tailored plans consider factors such as the
patient's cancer type, treatment regimen, and overall health status. Technology
is playing a significant role in market innovation. Mobile apps and digital
platforms are being used to facilitate communication between patients and
healthcare providers. These tools help patients track their dietary intake,
receive personalized nutrition guidance, and monitor their progress, improving
adherence to nutrition plans. Innovation in the oncology nutrition market has
fostered a patient-centered approach. Companies are focusing on patient
education and engagement, ensuring that patients are well-informed about the
importance of nutrition in their cancer journey. Patient-centered approaches
enhance treatment compliance and overall well-being. Companies are investing
heavily in research and development to drive innovation. This investment fuels
the creation of cutting-edge nutritional products and services. Research
efforts are directed toward understanding the nutritional needs of cancer
patients and developing solutions that address these needs comprehensively.

Download Free Sample Report
Key Market Challenges
Regulatory Hurdles
One of the primary challenges in the oncology nutrition market is
navigating the complex web of regulatory requirements. Different countries have
varying regulations regarding the production and distribution of nutritional
products and dietary supplements. Meeting these standards can be demanding and
time-consuming for companies operating on a global scale.
Treatment-Related Side Effects
Cancer treatments like chemotherapy and radiation therapy often lead to
debilitating side effects, including nausea, vomiting, and loss of appetite.
Developing nutrition solutions that can effectively address these side effects
and maintain the patient's nutritional status is a continuous challenge.
Patient Compliance
Ensuring patient compliance with recommended nutrition plans can be
challenging. Cancer patients may struggle with adherence due to factors like
taste changes, lack of appetite, or difficulty in swallowing. Educating and
motivating patients to follow their prescribed nutrition plans is a critical
challenge for healthcare providers.
Cost Constraints
Cancer patients often face significant financial burdens related to
their treatment, and the cost of specialized oncology nutrition products can be
prohibitive. Balancing the need for effective nutrition support with cost
constraints is a challenging aspect of market growth.
Key Market Trends
Nutrigenomics
Nutrigenomics is an emerging field that explores the interaction between
an individual's genetics and their dietary choices. In the oncology nutrition
market, this means using genetic information to create nutrition plans that are
specifically designed to target the unique needs and vulnerabilities of each
patient. This trend has the potential to revolutionize how we approach
nutrition in cancer care.
Digital Health Solutions
The integration of digital health solutions is set to revolutionize
oncology nutrition. Mobile apps, wearable devices, and telehealth platforms
will play a more prominent role in monitoring and managing patients'
nutritional needs. These tools will enable real-time tracking of dietary
intake, symptom management, and remote consultations with healthcare providers.
Functional Foods and Nutraceuticals
There is growing interest in the development of functional foods and
nutraceuticals tailored to the needs of cancer patients. These products go
beyond traditional supplements, offering targeted nutritional support with
added bioactive compounds that may help manage cancer-related symptoms and side
effects.
Sustainable and Ethical Nutrition
Sustainability and ethical considerations are becoming more prominent in
the oncology nutrition market. Patients and healthcare providers are showing
interest in nutrition products that are not only effective but also produced in
an environmentally responsible and ethically sourced manner.
Segmental Insights
Cancer Type Insights
Based on the category of Cancer Type, the lung cancer segment is
expected to experience growth throughout the study period due to several
factors. These include the global high prevalence of lung cancer, an increase
in the use of nutritional supplements for lung cancer patients, and a growing awareness
of the importance of incorporating nutritional supplements into one's diet. For
example, according to the Lung Cancer Fact 2022 report, lung cancer remains the
leading cause of cancer-related deaths worldwide. In the United States alone,
it was estimated that 236,740 individuals would be diagnosed with lung cancer
in 2022, with 1 in 16 people receiving a lung cancer diagnosis during their
lifetime (1 in 15 men and 1 in 17 women). With the rising number of cancer
patients, there is a growing recognition of the vital role nutrition plays in
bolstering the body's ability to combat disease and in providing the necessary
strength and stamina to endure the side effects of treatment. As a result, the
demand for oncology nutrition is expected to increase over the forecasted
period.
Additionally, government initiatives are actively promoting proper
nutrition for individuals undergoing cancer treatment and beyond. To support
this objective, regulatory agencies are streamlining and revising regulations
related to nutrition. As an example, in May 2021, U.S. Senators Susan Collins
(R-ME) and Gary Peters (D-MI) introduced bipartisan legislation known as the
"Medical Nutrition Therapy Act." This legislation aims to expand
Medicare Part B coverage to include medical nutrition therapy (MNT) services
for a broader range of conditions, including cancer, prediabetes, eating
disorders, malnutrition, gastrointestinal diseases (such as celiac disease),
cardiovascular disease, HIV/AIDS, and other conditions that result in
unintentional weight loss. Such policy initiatives are likely to provide
financial support to individuals and motivate them to be more proactive in
incorporating nutritional supplements into their routines, thereby fostering
growth in the market.
End User Insights
Hospital Pharmacy is poised to dominate the Global Oncology Nutrition
Market for several compelling reasons. Firstly, hospitals serve as primary hubs
for cancer diagnosis and treatment, making them central to the oncology care
continuum. As a result, they play a pivotal role in prescribing and
administering specialized oncology nutrition solutions tailored to individual
patient needs. Secondly, hospital pharmacies have the infrastructure and
expertise to manage complex pharmaceutical and nutritional requirements for
cancer patients, ensuring precise dosing, safety, and compliance. Thirdly, the
increasing incidence of cancer cases worldwide demands a consolidated and
regulated approach to oncology nutrition, which hospital pharmacies are
uniquely equipped to provide. Moreover, hospital pharmacies often collaborate
with multidisciplinary teams of oncologists, dietitians, and healthcare
professionals, ensuring a comprehensive and patient-centric approach to
nutrition therapy. These factors, coupled with the growing recognition of the
critical role of nutrition in cancer care, position hospital pharmacies as the
dominant players in the evolving Global Oncology Nutrition Market.

Download Free Sample Report
Regional Insights
North America is anticipated to experience growth in the overall
oncology nutrition market throughout the projected period. This can be
attributed to various factors, including the increasing prevalence of cancer
and the presence of advanced healthcare infrastructure, among other significant
drivers. For instance, the American Cancer Society's 2022 report estimates
approximately 1.9 million new cancer cases in the United States for the same
year. Additionally, initiatives by government bodies, new product launches, and
collaborations related to cancer nutrition supplements are contributing to
market expansion. For example, the "2022 Oncology Nutrition
Symposium" conducted by the Academy of Nutrition and Dietetics on June 20,
2022, addressed various aspects of oncology nutrition, encompassing research,
prevention, treatment, recovery, palliative care, and hospice.
Furthermore, the Canadian Cancer Society forecasts 233,900 new cancer
cases in Canada in 2022. The rising incidence of cancer cases across North
America is expected to fuel market growth. Moreover, the region conducts
numerous certification programs and awareness initiatives aimed at educating
cancer patients and healthcare providers about the significance of oncology
nutrition. One such example is the Oncology Nutrition Institute (ONI), which
offers evidence-based educational certification and training programs in
modern, metabolic, innovative, integrative, and outcomes-based oncology
nutrition therapy. Their flagship 250-hour Oncology Nutrition Consulting (ONC)
certification program is a comprehensive training course designed for qualified
nutrition, health, and medical practitioners. Consequently, the increasing
number of cancer cases is projected to drive demand for oncology nutrition,
ultimately stimulating market growth.
Recent Developments
- In July 2022, Nestle introduced China's inaugural Foods for Special
Medical Purpose (FSMP) designed for patients dealing with tumor-related
conditions. This achievement came after a rigorous five-year approval process
with Chinese regulatory authorities.
- In January 2022, Faeth Therapeutics successfully concluded a Series A
funding round, securing USD 47 million in private financing, with S2G Ventures
as the lead investor. This funding round brought their total capital raised to
USD 67 million thus far. The proceeds from this financing will be allocated
towards advancing Faeth's clinical trials, which employ a combination of
nutrient management, pharmaceuticals, and digital tools to inhibit the growth
of cancer.
Key Market Players
- Abbott Laboratories Inc
- Nestle
SA
- Fresenius
Kabi AG
- B
Braun SE
- Hormel
Foods Corporation
- Danone
SA
- MEIJI
Holdings Co Ltd
- Global
Health Products, Inc.
- Victus
Inc
- Mead
Johnson & Co LLC
By Cancer Type
|
By Nutrition
|
By Formula
|
By Distribution Channel
|
By End User
|
By Region
|
- Lung Cancer
- Head and Neck Cancer
- Stomach and Gastrointestinal Cancers
- Esophageal Cancer
- Liver Cancer
- Blood Cancer
- Others
|
- Enteral Nutrition
- Parenteral Nutrition
|
- Standard Formula
- Elemental Formula
- Specialized Formula
|
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
|
- Hospitals
- Homecare
- Specialty Clinics
|
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
|
Report Scope:
In this report, the Global Oncology Nutrition Market has been segmented
into the following categories, in addition to the industry trends which have
also been detailed below:
- Oncology Nutrition Market, By Cancer Type:
o Lung Cancer
o Head and Neck Cancer
o Stomach and Gastrointestinal Cancers
o Esophageal Cancer
o Liver Cancer
o Blood Cancer
o Others
- Oncology Nutrition Market, By Nutrition:
o Enteral Nutrition
o Parenteral Nutrition
- Oncology Nutrition Market, By Formula:
o
Standard Formula
o
Elemental Formula
o
Specialized Formula
- Oncology Nutrition Market, By Distribution Channel:
o
Hospital Pharmacy
o
Online Pharmacy
o
Retail Pharmacy
- Oncology Nutrition Market, By End User:
o
Hospitals
o
Homecare
o
Specialty Clinics
- Oncology Nutrition Market, By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ Germany
§ United Kingdom
§ France
§ Italy
§ Spain
o Asia-Pacific
§ China
§ Japan
§ India
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
§ Kuwait
Competitive Landscape
Company Profiles: Detailed
analysis of the major companies present in the Global Oncology Nutrition
Market.
Available Customizations:
Global Oncology Nutrition market report with the given market
data, Tech Sci Research offers customizations according to a company's specific
needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of
additional market players (up to five).
Global Oncology Nutrition Market is an upcoming report to be released
soon. If you wish an early delivery of this report or want to confirm the date
of release, please contact us at [email protected]